Dental Rehabilitation for a Child With Alopecia Areata Totalis: Case Report

Medical case reports have highlighted a potential link between dental infections and the development of alopecia areata (AA), a chronic inflammatory condition affecting the hair follicles. While AA is primarily understood as an autoimmune disorder, some clinical observations suggest that eliminating dental infectious processes can lead to the resolution of the condition in certain pediatric patients.

Alopecia areata is characterized by the sudden appearance of non-cicatricial hair loss, typically manifesting as round or oval patches. The condition can be restricted to a specific area or, in more severe forms such as alopecia areata totalis, result in more extensive loss. The scalp is the most common site affected, accounting for 90% of cases, though the face, eyebrows, eyelashes, underarm hair, and pubic hair can also be impacted.

The Autoimmune Mechanism of Alopecia Areata

Current medical evidence indicates that the inflammation of the hair follicle in AA is caused by a T-cell-mediated autoimmune mechanism. This process typically occurs in individuals who are genetically predisposed to the condition.

The incidence of the disease is reported between 0.1% and 0.2%, with a lifetime risk estimated at 1.7%. Pediatric cases constitute approximately 20% of all alopecia areata cases and affect males and females equally.

Global data shows varying prevalence in dermatology outpatient cases, accounting for roughly 2% of new cases in the United States and the United Kingdom, 3.8% in China, and 6.7% in Kuwait.

Dental Origin and Clinical Resolution

While standard treatments for AA often involve combined therapies, some cases have been linked to dental health. A case report published in the Indian Journal of Dental Research detailed the experience of a 9-year-old girl with alopecia areata of dental origin.

In this specific instance, the condition resolved after the management of the patient’s dental problem. This suggests that in some cases, the treatment for AA may consist of simply eliminating the dental infectious process.

The case involved complications related to dental caries, specifically involving a molar and root resorption. The resolution of these dental issues coincided with the resolution of the hair loss.

Standard Treatment Strategies for Pediatric AA

For the majority of patients, alopecia areata requires a multi-faceted approach to management. Common established treatments include:

• Topical or intralesional corticosteroids
• Immune therapy using diphenylcyclopropenone
• Psychotherapy to address the psychosocial morbidity associated with distressing hair loss

Management in children can be particularly challenging. A small proportion of pediatric cases experience a chronic relapsing course, which can lead to significant psychosocial distress.

Research into alternative treatments has also been conducted. For example, one case report noted no response in AA when using topical pimecrolimus, illustrating that treatment efficacy can vary significantly between patients.

Clinical Outlook and Considerations

The relationship between focal infections, such as those found in the oral cavity, and autoimmune responses remains a subject of clinical interest. The case of the 9-year-old girl demonstrates that addressing an underlying infectious trigger may be an effective intervention when the autoimmune response is linked to a dental origin.

Medical professionals continue to review second and third-line therapies to provide a comprehensive treatment algorithm for pediatric patients, aiming to mitigate the long-term impact of the disease on a child’s well-being.